These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1274 related articles for article (PubMed ID: 15577686)

  • 41. Stage- and Histologic Subtype-Dependent Frequency of Lymph Node Metastases in Patients with Epithelial Ovarian Cancer Undergoing Systematic Pelvic and Paraaortic Lymphadenectomy.
    Heitz F; Harter P; Ataseven B; Heikaus S; Schneider S; Prader S; Bommert M; Fisseler-Eckhoff A; Traut A; du Bois A
    Ann Surg Oncol; 2018 Jul; 25(7):2053-2059. PubMed ID: 29633097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.
    Petrillo M; Marchetti C; De Leo R; Musella A; Capoluongo E; Paris I; Benedetti Panici P; Scambia G; Fagotti A
    Am J Obstet Gynecol; 2017 Sep; 217(3):334.e1-334.e9. PubMed ID: 28549976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymphatic spread among women with primary peritoneal carcinoma.
    Eltabbakh GH; Mount SL
    J Surg Oncol; 2002 Nov; 81(3):126-31. PubMed ID: 12407724
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
    Moss EL; Evans T; Pearmain P; Askew S; Singh K; Chan KK; Ganesan R; Hirschowitz L
    Int J Gynecol Cancer; 2015 Sep; 25(7):1201-7. PubMed ID: 26035124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skin metastases in ovarian carcinoma: a report of nine cases and a review of the literature.
    Cormio G; Capotorto M; Di Vagno G; Cazzolla A; Carriero C; Selvaggi L
    Gynecol Oncol; 2003 Sep; 90(3):682-5. PubMed ID: 13678747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Lobular invasive breast cancer prognostic factors: About 940 patients].
    Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
    Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Serous papillary cancer of the peritoneum: a multicentric primary disease].
    Maassen V; Debus-Thiede G
    Zentralbl Gynakol; 1993; 115(8):347-54. PubMed ID: 8212940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The involvement of retroperitoneal lymph nodes in primary serous-papillary peritoneal carcinoma. a systematic review of the literature.
    Steinhagen PR; Sehouli J
    Anticancer Res; 2011 Apr; 31(4):1387-94. PubMed ID: 21508390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ovarian carcinoma metastatic to the breast.
    Wadhwa J; Dawar R; Kumar L
    Clin Oncol (R Coll Radiol); 1999; 11(6):419-21. PubMed ID: 10663336
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases.
    Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J
    Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Axillary lymph node metastases associated with small invasive breast carcinomas.
    Maibenco DC; Weiss LK; Pawlish KS; Severson RK
    Cancer; 1999 Apr; 85(7):1530-6. PubMed ID: 10193943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
    Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
    Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uterine papillary serous carcinoma presenting as distant lymph node metastasis.
    Ng JS; Han AC; Edelson MI; Rosenblum NG
    Gynecol Oncol; 2001 Mar; 80(3):417-20. PubMed ID: 11263944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study.
    Ayhan A; Ozkan NT; Sarı ME; Celik H; Dede M; Akbayır Ö; Güngördük K; Şahin H; Haberal A; Güngör T; Arvas M; Meydanlı MM
    J Gynecol Oncol; 2018 Jan; 29(1):e12. PubMed ID: 29185270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
    Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early recurrence of ovarian serous borderline tumor as high-grade carcinoma: a report of two cases.
    Parker RL; Clement PB; Chercover DJ; Sornarajah T; Gilks CB
    Int J Gynecol Pathol; 2004 Jul; 23(3):265-72. PubMed ID: 15213603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence of para-aortic and pelvic lymph node metastases in epithelial carcinoma of the ovary.
    Chen SS; Lee L
    Gynecol Oncol; 1983 Aug; 16(1):95-100. PubMed ID: 6884834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas.
    Cass I; Li AJ; Runowicz CD; Fields AL; Goldberg GL; Leuchter RS; Lagasse LD; Karlan BY
    Gynecol Oncol; 2001 Jan; 80(1):56-61. PubMed ID: 11136570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum.
    Seidman JD; Horkayne-Szakaly I; Cosin JA; Ryu HS; Haiba M; Boice CR; Yemelyanova AV
    Gynecol Oncol; 2006 Nov; 103(2):703-8. PubMed ID: 16828848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.